Scientists at the UNC School of Medicine and NC State have created an injectable gel - like scaffold that can hold combination chemo - immunotherapeutic drugs and deliver them locally to tumours in a sequential manner.
CALM study: secondary endpoints of a phase II study of a novel oncolytic immunotherapeutic agent, coxsackievirus A21, delivered intratumorally in patients with advanced malignant melanoma.